$32.21
0%
Price vs. AI Score (Last 150 days)
Data gathered: November 30
Data gathered: November 30
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 18 5.9% |
|
| Sentiment | 54 0% |
|
| Webpage traffic | 38,000 6.9% |
|
| Employee Rating | 62 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 16 100% |
|
| Facebook followers | 605 0% |
|
| Stocktwits Mentions | 2 0% |
|
| Stocktwits Subscribers | 3,163 0.1% |
|
| Twitter Followers | 1,553 -0.1% |
|
| Youtube Subscribers | 404 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 43 0% |
|
In the news
Analysts Offer Insights on Healthcare Companies: Agilent (A), Cytokinetics (CYTK) and Aligos Therapeutics (ALGS)November 21 - TipRanks |
|
Cytokinetics call volume above normal and directionally bullishNovember 20 - Thefly.com |
|
Needham healthcare analysts hold an analyst/industry conference callNovember 19 - Thefly.com |
|
Truist biotech analyst to hold an analyst/industry conference callNovember 16 - Thefly.com |
|
Prospective Growth for Cytokinetics: A Comprehensive Analysis of Aficamten’s Potential and Market ImpactNovember 15 - TipRanks |
About Cytokinetics
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
| Price | $32.21 |
| Target Price | Sign up |
| Market Cap | $3.12B |
| Dividend Yield | 0.0146 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 380,000 | 40M | -47M | -129M | -115M |
| Q2 '23 | 870,000 | 40M | -46M | -129M | -115M |
| Q1 '23 | 4.6M | 50M | -52M | -131M | -118M |
| Q4 '22 | 2M | 54M | -59M | -137M | -121M |
| Q3 '22 | 2.5M | 48M | -53M | -142M | -103M |
Insider Transactions
| Malik Fady Ibraham filed to sell 150,664 shares at $35.4. November 9 '23 |
| Blum Robert I filed to sell 441,417 shares at $32.2. October 30 '23 |
| Blum Robert I filed to sell 441,417 shares at $33.7. October 16 '23 |
| Malik Fady Ibraham filed to sell 153,164 shares at $35.9. October 12 '23 |
| Blum Robert I filed to sell 441,417 shares at $30. October 6 '23 |
Read more about Cytokinetics and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, reddit mentions, business outlook.